Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05120999 · ClinicalTrials.gov registry record
Comparison of Onset of Neuromuscular Blockade With Electromyographic and Acceleromyographic Monitoring
A clinical trial of Neuromuscular Blockade, sponsored by Mayo Clinic.
- Completed
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT05120999 is a study of Neuromuscular Blockade that has completed, run by Mayo Clinic. The registered enrollment target is 100 participants, below the 11,824-participant average among 6 other Neuromuscular Blockade trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05120999, a study of Neuromuscular Blockade, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to use 2 devices to compare the difference in the amount of time it takes for each device to register complete muscle relaxation after the muscle relaxing medication is given. The comparison will be made by using electromyographic (EMG), such as TetraGraph, and acceloromyographic (AMG), such as TOFScan, monitors at the time of insertion of breathing tube.
Conditions Studied
Interventions
- DEVICE Train of four measurement
Study Locations (1)
Florida
- Mayo Clinic in Florida - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2021-10-25 |
| Est. Completion | 2022-01-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05120999
The ClinicalTrials.gov registry entry for NCT05120999 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 11,824-participant average among 6 other Neuromuscular Blockade trials with a reported enrollment target (99% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Neuromuscular Blockade appearing as the primary indexed condition, and to 1 intervention - of which Train of four measurement is the first listed.
NCT05120999 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT05120999 about?
NCT05120999 is a clinical study titled "Comparison of Onset of Neuromuscular Blockade With Electromyographic and Acceleromyographic Monitoring". The purpose of this research is to use 2 devices to compare the difference in the amount of time it takes for each device to register complete muscle relaxation after the muscle relaxing medication is given. The comparison will be made by using electromyographic (EMG), such as TetraGraph, and accelo...
What is the current status of trial NCT05120999?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2021-10-25. Estimated completion is 2022-01-14.
What conditions does trial NCT05120999 study?
This clinical trial studies the following conditions: Neuromuscular Blockade.
What interventions are being tested in trial NCT05120999?
The interventions under investigation include: Train of four measurement (DEVICE).
Who is sponsoring clinical trial NCT05120999?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05120999 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neuromuscular Blockade
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease
RECRUITING · Phase 4
-
Median Versus Ulnar Nerve Quantitative Electromyography Neuromuscular Blockade Monitoring Comparison
RECRUITING
-
NMBA Reversal and Postoperative Urinary Retention
ACTIVE NOT RECRUITING
-
Understanding the Cognition and Decision Making of Community Anesthesiologists
COMPLETED
-
Sugammadex Versus Neostigmine for Reversal of Rocuronium Neuromuscular
COMPLETED · Phase 4
-
The Effect of Sugammadex Versus Neostigmine on Postoperative Pulmonary Complications
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.